Agilent Technologies Inc. today announced the launch of its latest innovation in liquid chromatography (LC)-mass detection: the Agilent InfinityLab Pro iQ Series. This groundbreaking series includes the InfinityLab Pro iQ and the InfinityLab Pro iQ Plus, each tailored with distinct features and capabilities to meet the diverse analytical needs of modern laboratories.

安捷伦科技公司今日宣布推出其在液相色谱（LC）质谱检测领域的最新创新产品：Agilent InfinityLab Pro iQ 系列。这一突破性系列包括 InfinityLab Pro iQ 和 InfinityLab Pro iQ Plus，每一款都具备独特的功能和性能，旨在满足现代实验室多样化的分析需求。

These advanced, intelligent systems are particularly well-suited for analyzing essential molecules such as therapeutic small molecules, oligonucleotides, peptides, and proteins..

这些先进的智能系统特别适合分析基本分子，如治疗性小分子、寡核苷酸、肽和蛋白质。

The Pro iQ Series is designed to serve a broad range of end markets, including pharmaceutical and biopharmaceutical industries, academic and government research institutions, environmental testing labs, food safety organizations, and the chemical and specialty materials sector. With its precision, sensitivity, and intelligent design, the series supports applications such as mass confirmation, impurity profiling, biomolecule characterization, trace contaminant detection, and compound purification—empowering scientists to achieve high-quality, reliable results in both routine and advanced analytical workflows. .

Pro iQ 系列旨在服务于广泛的终端市场，包括制药和生物制药行业、学术和政府研究机构、环境测试实验室、食品安全组织以及化学和特种材料领域。凭借其精确性、灵敏性和智能设计，该系列支持多种应用，如质量确认、杂质分析、生物分子表征、痕量污染物检测和化合物纯化，助力科学家在常规和高级分析工作流程中获得高质量、可靠的结果。

Dr. Iris Mangelschots, vice president and general manager of Agilent’s Liquid Phase Division, emphasized the strategic significance of the launch:

安捷伦液相事业部副总裁兼总经理Iris Mangelschots博士强调了此次发布的战略意义：

“With the launch of the Pro iQ Series, Agilent is redefining the future of liquid chromatography detection and demonstrating our continuing commitment to delivering leading-edge solutions to help customers push the boundaries of scientific discovery. The advanced Pro iQ Series will empower researchers to achieve unprecedented levels of insight and efficiency, making complex analyses more accessible and sustainable.” .

“随着Pro iQ系列的推出，安捷伦重新定义了液相色谱检测的未来，并展示了我们持续致力于提供前沿解决方案以帮助客户突破科学发现界限的决心。先进的Pro iQ系列将使研究人员能够达到前所未有的洞察力和效率水平，使复杂分析变得更加便捷和可持续。”

The Pro iQ Series delivers exceptional performance and sensitivity, making it ideal for monitoring complex biomolecules and detecting impurities. Whether analyzing therapeutic small molecules, oligonucleotides, peptides, or proteins, the systems provide robust, high-resolution data to ensure accuracy, safety, and stability.

Pro iQ 系列提供卓越的性能和灵敏度，是监测复杂生物分子和检测杂质的理想选择。无论是分析治疗性小分子、寡核苷酸、肽还是蛋白质，该系统都能提供稳健的高分辨率数据，确保准确性、安全性和稳定性。

The series also enables mass-based purification, allowing precise isolation of target compounds for downstream applications..

该系列还支持基于质量的纯化，允许为下游应用精确分离目标化合物。

The Pro iQ Plus system is engineered for high-end applications that demand ultimate sensitivity and performance. With an expanded mass range of m/z 2–3,000 and enhanced sensitivity through Agilent Jet Stream (AJS) technology, it supports both routine and trace-level detection of small and large molecules.

Pro iQ Plus 系统专为要求极致灵敏度和性能的高端应用而设计。其质荷比范围扩展至 m/z 2–3,000，并通过安捷伦喷射流 (AJS) 技术提升了灵敏度，能够支持小分子和大分子的常规及痕量检测。

These capabilities make it especially valuable in advanced R&D environments where extended analytical performance is critical..

这些能力使其在需要延长分析性能的先进研发环境中尤其有价值。

Both the Pro iQ and Pro iQ Plus systems are designed for operational efficiency and ease of use, enabling faster compound confirmation with greater specificity and selectivity than traditional UV detection—even for chromatographically unresolved compounds. The Pro iQ system, with a mass range of m/z 2–1,600, is optimized for small molecule analysis, making it a reliable choice for standard laboratory workflows..

Pro iQ 和 Pro iQ Plus 系统均以操作效率和使用便捷性为设计目标，能够比传统的紫外检测更快地确认化合物，并具有更高的特异性和选择性，即使对于色谱未分离的化合物也同样适用。Pro iQ 系统的质量范围为 m/z 2–1,600，专为小分子分析优化，是标准实验室工作流程的可靠选择。

Jennifer Gushue, associate vice president of LC/MS Product Marketing at Agilent, highlighted the broad applicability of the new systems:

安捷伦LC/MS产品营销副总裁Jennifer Gushue强调了新系统的广泛适用性：

“The versatility of the Pro iQ Series opens new possibilities across a wide spectrum of application areas—from pharmaceutical development and quality control to biotherapeutics, environmental testing, and academic research. Whether it's ensuring the purity of life-saving drugs, characterizing complex biomolecules—such as oligonucleotides and peptides—or advancing cutting-edge research, these systems deliver the precision, sensitivity, and intelligence today’s scientists need to solve tomorrow’s challenges.”.

“Pro iQ系列的多功能性在广泛的应用领域中开辟了新的可能性——从药物开发和质量控制到生物治疗、环境测试和学术研究。无论是确保救命药物的纯度、表征复杂的生物分子（如寡核苷酸和肽），还是推动前沿研究，这些系统都提供了当今科学家所需的精确性、灵敏度和智能化，以解决未来的挑战。”

About Agilent Technologies

安捷伦科技公司简介

Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions.

安捷伦科技公司（纽约证交所代码：A）是分析和临床实验室技术的全球领导者，提供洞察力和创新成果，帮助客户将卓越的科学付诸实践。安捷伦全面的解决方案包括仪器、软件、服务和专业知识，为客户提供值得信赖的答案，解决他们最具挑战性的问题。

The company generated revenue of $6.51 billion in fiscal year 2024 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook..

该公司在2024财年创造了65.1亿美元的收入，并在全球范围内雇用了大约18,000名员工。有关安捷伦的信息可访问www.agilent.com。要获取最新的安捷伦新闻，请订阅安捷伦新闻中心。在LinkedIn和Facebook上关注安捷伦。